VUKOTIC, Ranka
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.083
EU - Europa 639
AS - Asia 255
SA - Sud America 8
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.075
SE - Svezia 188
GB - Regno Unito 166
HK - Hong Kong 116
CN - Cina 89
IT - Italia 87
DE - Germania 58
BG - Bulgaria 38
FI - Finlandia 32
UA - Ucraina 20
TR - Turchia 15
CA - Canada 8
RO - Romania 6
BE - Belgio 5
EG - Egitto 5
FR - Francia 5
LT - Lituania 5
NL - Olanda 5
BR - Brasile 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
JP - Giappone 3
KR - Corea 3
MY - Malesia 3
PL - Polonia 3
RU - Federazione Russa 3
SG - Singapore 3
VN - Vietnam 3
CH - Svizzera 2
CO - Colombia 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
IN - India 2
IR - Iran 2
PH - Filippine 2
QA - Qatar 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ID - Indonesia 1
KW - Kuwait 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.994
Salva come PNG Salva come JPEG
Città #
Fairfield 313
Chandler 302
Ashburn 215
Nyköping 157
Houston 150
Woodbridge 124
Hong Kong 115
Cambridge 108
Southend 104
Wilmington 104
Seattle 94
San Diego 51
Ann Arbor 49
Dearborn 44
Princeton 41
Sofia 38
Jacksonville 30
Helsinki 28
Modena 25
New York 22
Beijing 18
Redwood City 16
Izmir 13
Shanghai 12
Bremen 10
Nanjing 10
Falls Church 9
Grafing 9
Guangzhou 9
Kilburn 9
Augusta 8
Chiswick 8
Eugene 8
London 8
Bologna 6
Hounslow 6
Norwalk 6
Toronto 6
Wuhan 6
Brussels 5
Cairo 5
San Mateo 5
Brooklyn 4
Des Moines 4
San Jose 4
São Paulo 4
Andover 3
Baotou 3
Berlin 3
Boardman 3
Chicago 3
Kuala Lumpur 3
Santa Rosa 3
Vienna 3
Acton 2
Amsterdam 2
Athens 2
Budrio 2
Dong Ket 2
Dublin 2
Fabriano 2
Frankfurt am Main 2
Glendale 2
Hefei 2
Kemerovo 2
Leawood 2
Lucca 2
Milan 2
Ottawa 2
Palermo 2
Phoenix 2
Sabbio Chiese 2
Salt Lake City 2
San Cesario di Lecce 2
Seongnam 2
Tokyo 2
Wenzhou 2
Worthing 2
Zagreb 2
Zgierz 2
Ardabil 1
Bari 1
Baveno 1
Brandon 1
Brentford 1
Brno 1
Calcinaia 1
Castel Maggiore 1
Central 1
Cilacap 1
Daejeon 1
Doha 1
Doncaster 1
Dubai 1
Dung 1
Durham 1
Eden Prairie 1
Florence 1
Groningen 1
Gunzenhausen 1
Totale 2.418
Salva come PNG Salva come JPEG
Nome #
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 222
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 214
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 194
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 167
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 166
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 162
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 161
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 146
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 73
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 71
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 67
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 67
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 66
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 62
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 60
Hepatitis B virus and immune response 59
Clinical and serological profile of primary biliary cirrhosis in men 59
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 59
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 56
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 54
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 54
Familial intrahepatic cholestasis: New and wide perspectives 53
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 50
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 50
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 49
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 49
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 46
Insights into cancer severity from biomolecular interaction mechanisms 46
Impact of psychosocial status on liver transplant process 46
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 45
Bone marrow derived stem cells for the treatment of end-stage liver disease 45
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 44
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 43
Hepatitis C Virus Core Antigen (HCVAg): An affordable assay to monitor the efficacy of treatment in DAAs era 42
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 41
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 41
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 38
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 36
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 33
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 23
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 2
Totale 3.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019114 0 0 0 0 0 0 0 0 0 0 38 76
2019/2020333 21 13 4 14 32 83 67 31 30 16 15 7
2020/2021581 23 13 23 43 30 35 24 37 183 24 127 19
2021/2022726 58 30 40 40 16 51 23 87 83 77 123 98
2022/2023746 108 105 69 78 74 114 11 67 81 4 21 14
2023/2024379 21 25 27 70 102 21 43 47 5 6 12 0
Totale 3.061